48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?

(2023) Flavius-Alexandru Gherasie et al.   Journal of Personalized Medicine

Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial

(2023) Marco Valgimigli et al.   CIRCULATION

2023 ESC Guidelines for the management of acute coronary syndromes

(2023) Robert A Byrne et al.   EUROPEAN HEART JOURNAL

Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results

(2023) Maciej Tyczyński et al.   Journal of Clinical Medicine

Preferable vascular healing of ultrathin strut biodegradable-polymer sirolimus-eluting stents in patients with acute coronary syndrome

(2022) Akito Kawamura et al.   Cardiovascular Intervention and Therapeutics

Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials

(2022) Rayyan Hemetsberger et al.   Clinical Research in Cardiology

Surgical Turned-Downed CHIP Cases—Can PCI Save the Day?

(2022) Alexandru Achim et al.   Frontiers in Cardiovascular Medicine

Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study

(2022) Yutaka Matsuhiro et al.   Cardiovascular Intervention and Therapeutics

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review

(2022) Attilio Leone et al.   Journal of Personalized Medicine

Differential impact of abluminal groove‐filled biodegradable‐polymer sirolimus‐eluting stent versus durable‐polymer everolimus‐eluting stent on and off dual antiplatelet therapy

(2021) Yuichi Saito et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study

(2021) Petr Toušek et al.   CARDIOVASCULAR DRUGS AND THERAPY

Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial

(2021) Juan F. Iglesias et al.   Cardiovascular Revascularization Medicine

Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)

(2020) Mario Iannaccone et al.   BMC Cardiovascular Disorders

Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest

(2020) Mohamed A. Omer et al.   JACC-Cardiovascular Interventions

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?

(2019) Mateusz P. Jeżewski et al.   Journal of Clinical Medicine

Coronary Stents: History, Design, and Construction

(2018) Torrey Schmidt et al.   Journal of Clinical Medicine

Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients

(2018) Ariel Roguin et al.   Circulation-Cardiovascular Interventions

Fourth universal definition of myocardial infarction (2018)

(2018) Kristian Thygesen et al.   EUROPEAN HEART JOURNAL

Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial

(2017) Hui-liang Liu et al.   Journal of Cardiology

Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model

(2016) Piotr P. Buszman et al.   Cardiology Journal

Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis

(2015) Jacek Bil et al.   BMC Cardiovascular Disorders

Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome

(2015) Pasi P. Karjalainen et al.   CIRCULATION JOURNAL

A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction

(2015) Takumi Higuma et al.   JACC-Cardiovascular Interventions

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents

(2013) Tomohisa Tada et al.   JACC-Cardiovascular Interventions

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

(2013) Vasim Farooq et al.   LANCET

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

(2011) Sanjit S Jolly et al.   LANCET